Search hospitals > Pennsylvania > Harrisburg
UPMC Pinnacle Cancer Center/Community Osteopathic Campus
Claim this profileHarrisburg, Pennsylvania 17109
Global Leader in Skin Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
90 reported clinical trials
24 medical researchers
Summary
UPMC Pinnacle Cancer Center/Community Osteopathic Campus is a medical facility located in Harrisburg, Pennsylvania. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. UPMC Pinnacle Cancer Center/Community Osteopathic Campus is involved with conducting 90 clinical trials across 143 conditions. There are 24 research doctors associated with this hospital, such as Liza C. Villaruz, Adam Brufsky, MD, Dan P. Zandberg, and Alexander B. Olawaiye.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
ER positive
HER2 negative
Top PIs
Liza C. VillaruzUniversity of Pittsburgh Cancer Institute (UPCI)6 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
40 reported clinical trials
59 drugs studied
Adam Brufsky, MDUniversity of Pittsburgh Cancer Institute (UPCI)1 year of reported clinical research
Expert in Breast Cancer
Expert in Breast cancer
31 reported clinical trials
70 drugs studied
Dan P. ZandbergUniversity of Pittsburgh Cancer Institute (UPCI)4 years of reported clinical research
Expert in Skin Cancer
Expert in Squamous Cell Carcinoma
20 reported clinical trials
36 drugs studied
Alexander B. OlawaiyeUniversity of Pittsburgh Cancer Institute (UPCI)2 years of reported clinical research
Expert in Ovarian Cancer
Studies Skin Cancer
21 reported clinical trials
45 drugs studied
Clinical Trials running at UPMC Pinnacle Cancer Center/Community Osteopathic Campus
Breast Cancer
Lung Cancer
Prostate Cancer
Skin Cancer
Non-Small Cell Lung Cancer
Bladder Cancer
Breast cancer
Small Cell Lung Cancer
Kidney Cancer
Squamous Cell Carcinoma
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Low Dose Tamoxifen
for Breast Cancer
This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive, HER2 negative early stage breast cancer. Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow. Aromatase inhibitors, such as anastrozole, letrozole, and exemestane, prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy to treat postmenopausal women with hormone-dependent breast cancer. Giving low dose tamoxifen may be more effective compared to usual hormone therapy in treating post-menopausal women with hormone-positive, HER2 negative early stage breast cancer.
Recruiting2 awards Phase 38 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at UPMC Pinnacle Cancer Center/Community Osteopathic Campus?
UPMC Pinnacle Cancer Center/Community Osteopathic Campus is a medical facility located in Harrisburg, Pennsylvania. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. UPMC Pinnacle Cancer Center/Community Osteopathic Campus is involved with conducting 90 clinical trials across 143 conditions. There are 24 research doctors associated with this hospital, such as Liza C. Villaruz, Adam Brufsky, MD, Dan P. Zandberg, and Alexander B. Olawaiye.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.